HCA (HCA Healthcare) Tariff Resilience Score: 7/10 (As of Jul. 07, 2026)


HCA HCA Healthcare Inc HCA
87 GF Score
Price $417.07
GF Value $452.70
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is HCA Healthcare Tariff Resilience Score?

HCA Healthcare HCA +1.60% 87 Tariff Resilience Score is 7 as of Jul. 07, 2026. GuruFocus rates HCA with a GF Score™ of 87/100 and a GF Value™ of $452.70 (Fairly Valued). The stock has 2 warning signs investors should review. Among 672 Healthcare Providers & Services companies, HCA Healthcare ranks better than 89.14% on this metric.

HCA Healthcare has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

HCA Healthcare has Healthcare provider with domestic focus. Limited direct exposure to tariffs, but potential indirect impact through medical equipment supply chains. Generally resilient due to domestic market focus.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes HCA Healthcare might have Highly Resilient.

HCA Healthcare  (NYSE:HCA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

HCA Healthcare Tariff Resilience Score Related Terms

HCA vs THC, DVA, EHC: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, HCA Healthcare's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HCA Healthcare Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HCA Healthcare's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where HCA Healthcare's Tariff Resilience Score falls into.


HCA
87GF Score
HCA Healthcare Inc HCA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
HCA Healthcare (HCA) has a Tariff Resilience Score of 7 as of Jul. 07, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, HCA Healthcare ranks #73 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 10.9%.
Is HCA Healthcare's Tariff Resilience Score too high?
HCA Healthcare's current Tariff Resilience Score is 7. Based on the distribution chart, HCA Healthcare ranks #73 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, HCA Healthcare has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HCA Healthcare's Tariff Resilience Score compare to THC and DVA?
According to the Healthcare Providers & Services industry distribution chart, HCA Healthcare ranks #73 out of 672 companies for Tariff Resilience Score. This places HCA Healthcare in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. HCA Healthcare's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCA Healthcare stock overvalued right now?
Based on GuruFocus' analysis, HCA Healthcare (HCA) is currently considered Fairly Valued. The stock's GF Value™ is $452.70, compared to a current price of $417.07 — trading 7.9% below its estimated fair value. The current Tariff Resilience Score is 7. HCA Healthcare's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For HCA Healthcare (HCA), the current Tariff Resilience Score is 7 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HCA Healthcare (HCA) Overvalued in 2026?

Based on GuruFocus' analysis, HCA Healthcare stock appears to be undervalued. The current stock price of $417.07 is trading 7.9% below its estimated GF Value™ of $452.70. GuruFocus considers HCA Healthcare to be Fairly Valued.

Key valuation signals for HCA:

  • Tariff Resilience Score: 7
  • GF Value™: $452.70 vs. price of $417.07 (7.9% below fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the HCA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HCA Healthcare Business Description

Address One Park Plaza, Nashville, TN, USA, 37203
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
87GF Score

Get the complete analysis for HCA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$417.07
Price
$452.70
GF Value